Beroni Group Limited BNIGF
Set alert
At close · Oct 30
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0021
- Prev close
- 0.0064
- Mkt cap
- 217.52K
- Vol
- 27
- Avg vol
- 0
- EPS
- -0.15
- P/E
- 0.00
More statistics
- Low
- 0.0021
- High
- 0.0021
News
5 years ago globenewswire.com
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
NEW YORK and SYDNEY, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO…
5 years ago globenewswire.com
Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans
NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today…
5 years ago globenewswire.com
Beroni Group's SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
NEW YORK and SYDNEY, Australia, April 27, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today…
5 years ago globenewswire.com
Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company
NEW YORK and SYDNEY, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announces that it…